Optimal and suboptimal protocols for a mathematical model for
tumor anti-angiogenesis in combination with chemotherapy
-
1.
Dept. of Mathematics and Statistics, Southern Illinois University Edwardsville, Edwardsville, Illinois, 62026-1653
-
2.
Institut für Numerische und Angewandte Mathematik, Universität Münster, D-48149 Münster
-
3.
Dept. of Electrical and Systems Engineering, Washington University, St. Louis, Missouri, 63130-4899
-
Received:
01 March 2010
Accepted:
29 June 2018
Published:
01 April 2011
-
-
MSC :
Primary: 92C50; Secondary: 49K15, 49M99.
-
-
We consider the problem of minimizing the tumor volume with a priori
given amounts of anti-angiogenic and cytotoxic agents. For one
underlying mathematical model, optimal and suboptimal solutions are
given for four versions of this problem: the case when only
anti-angiogenic agents are administered, combination treatment with
a cytotoxic agent, and when a standard linear pharmacokinetic
equation for the anti-angiogenic agent is added to each of these
models. It is shown that the solutions to the more complex models
naturally build upon the simplified versions. This gives credence to
a modeling approach that starts with the analysis of simplified
models and then adds increasingly more complex and medically
relevant features. Furthermore, for each of the problem formulations
considered here, there exist excellent simple piecewise constant
controls with a small number of switchings that virtually replicate
the optimal values for the objective.
Citation: Urszula Ledzewicz, Helmut Maurer, Heinz Schättler. Optimal and suboptimal protocols for a mathematical model for tumor anti-angiogenesis in combination with chemotherapy[J]. Mathematical Biosciences and Engineering, 2011, 8(2): 307-323. doi: 10.3934/mbe.2011.8.307
-
Abstract
We consider the problem of minimizing the tumor volume with a priori
given amounts of anti-angiogenic and cytotoxic agents. For one
underlying mathematical model, optimal and suboptimal solutions are
given for four versions of this problem: the case when only
anti-angiogenic agents are administered, combination treatment with
a cytotoxic agent, and when a standard linear pharmacokinetic
equation for the anti-angiogenic agent is added to each of these
models. It is shown that the solutions to the more complex models
naturally build upon the simplified versions. This gives credence to
a modeling approach that starts with the analysis of simplified
models and then adds increasingly more complex and medically
relevant features. Furthermore, for each of the problem formulations
considered here, there exist excellent simple piecewise constant
controls with a small number of switchings that virtually replicate
the optimal values for the objective.
-
-
-
-